Mine-Chie Hung

65PUBLICATIONS
363CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsAutoimmunityMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (65)

|Jul 04, 2026
CAF-derived PAI-1 serves as an EGFR ligand and fuels KRAS-mutant pancreatic cancer.

|Jul 03, 2026
Galectin-9-driven immune evasion constrains radiotherapy-induced systemic antitumor immunity.

|May 11, 2026
All-trans retinoic acid destabilizes ADAR1 protein through retinoylation-mediated USP7 dissociation and improves immunotherapy in pancreatic cancer.

|Jan 21, 2026
ZNF683+ NK cells govern chemotherapy sensitivity in advanced HPSCC via reshaping immune microenvironment.

Guo Li, Wenhao Xiao, Haijun Wu

|Jan 21, 2026
A genome-wide genetic screen reveals the P2Y2-integrin axis as a stabilizer of EGFR mutants in non-small cell lung cancer (NSCLC).

Yafei Du, Wenjing Wang, Hui Chin Goh

|Oct 31, 2025
ZNF334 truncation mutation drives cold-induced autoinflammation.

Joung-Liang Lan, Shih-Hsin Chang, Yi-Hua Lai

Pageof 11

Frequent Collaborators

9 joint publications

Dihua Yu

5 joint publications

Yao Jun

5 joint publications

Liuqing Yang

5 joint publications

Chunru Lin